Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4799343
Max Phase: Preclinical
Molecular Formula: C45H69F2N9O7
Molecular Weight: 886.10
Molecule Type: Unknown
Associated Items:
ID: ALA4799343
Max Phase: Preclinical
Molecular Formula: C45H69F2N9O7
Molecular Weight: 886.10
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1cccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1
Standard InChI: InChI=1S/C45H69F2N9O7/c1-30(2)43-54-53-31(3)56(43)37-24-35-13-14-36(25-37)55(35)22-17-38(52-44(61)32-15-18-45(46,47)19-16-32)33-11-10-12-34(23-33)51-42(60)29-63-28-41(59)50-21-9-7-5-6-8-20-49-40(58)27-62-26-39(57)48-4/h10-12,23,30,32,35-38H,5-9,13-22,24-29H2,1-4H3,(H,48,57)(H,49,58)(H,50,59)(H,51,60)(H,52,61)/t35-,36+,37+,38-/m0/s1
Standard InChI Key: MLGQOQNDODXNHW-LQDUMDOSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 886.10 | Molecular Weight (Monoisotopic): 885.5288 | AlogP: 4.85 | #Rotatable Bonds: 25 |
Polar Surface Area: 197.91 | Molecular Species: BASE | HBA: 11 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.87 | CX Basic pKa: 9.27 | CX LogP: 1.24 | CX LogD: -0.63 |
Aromatic Rings: 2 | Heavy Atoms: 63 | QED Weighted: 0.09 | Np Likeness Score: -0.96 |
1. Arnatt CK,Falls BA,Yuan Y,Raborg TJ,Masvekar RR,El-Hage N,Selley DE,Nicola AV,Knapp PE,Hauser KF,Zhang Y. (2016) Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization., 24 (22.0): [PMID:27720326] [10.1016/j.bmc.2016.09.059] |
Source(1):